You can read the full article at Tirzepatide is a new medication being studied for its effectiveness and safety in treating type 2 diabetes
Epub 2017 Aug 30
Weight loss and improved blood sugar levels typically become more noticeable after 48 weeks, with continued improvement over several months
Most common side effects are gastrointestinal
doi:10.2174/157015909787602788 Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, ONeil GN, BG-12 Phase IIb Study Investigators (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study